Literature DB >> 20378176

Posterior fossa imaging in 158 children with ataxia.

N Boddaert1, I Desguerre, N Bahi-Buisson, S Romano, V Valayannopoulos, Y Saillour, D Seidenwurm, D Grevent, L Berteloot, A-S Lebre, M Zilbovicius, S Puget, R Salomon, T Attie-Bitach, A Munnich, F Brunelle, P de Lonlay.   

Abstract

OBJECTIFS: To propose a MRI cerebellar algorithm that may be applied to guide genetic/malformative or biochemical investigations for patients with cerebellar ataxia. PATIENTS AND METHODS: Cerebral MRI of 158 patients with cerebellar ataxia and no supratentorial abnormality were examined according to a new categorization system based on posterior fossa imaging. The clinical and radiological findings were confronted to biochemical and/or genetic results using the MR cerebellar algorithm. Seven groups of cerebellar MRI pattern were described: vermian dysgenesis (n=27), cerebellar hypoplasia (n=15), hemispheric cerebellar dysgenesis (n=6), unilateral hemispheric atrophy (n=5), global cerebellar atrophy (n=84), signal abnormalities (n=11) and normal MRI (n=10). Cerebellar hypoplasia, vermian dysgenesis and hemispheric cerebellar dysgenesis groups were classified as malformative disorders. Global atrophy and signal abnormality groups were classified as metabolic disorders.
RESULTS: In the vermian dysgenesis group, a specific genetic diagnosis was obtained in eight children (8/27) and all of the mutated genes (AHI1 (JBS3), CEP290 (JBS5), TMEM67 (JBS6), and RPGRIP1L (JBS7)) are involved in primary cilia function. In the group of pontocerebellar hypoplasia specific genetic diagnosis was obtained in one patient (PCH2) (1/15). Thus, nine of 42 children classified as malformative disorder had a molecular diagnosis. Global atrophy and signal abnormality groups were classified as metabolic disorders, specific biochemical was obtained in 46/95 children. In global atrophy group, respiratory chain deficiency was diagnosed in 18 children (18/84). In 21 children a congenital disorders of glycosylation type 1a (CDG Ia) was diagnosed (21/84) and infantile neuroaxonale dystrophy (INAD) was diagnosed in one child. In signal abnormalities group, specific biochemical diagnosis was obtained in six out of 11 children, five children with respiratory chain deficiency and one child with sulphite oxidase deficiency. In hemispheric cerebellar dysgenesis and normal MRI groups, no biological diagnosis was found for any of the patients. In the group of unilateral hemispheric atrophy, we hypothesized a clastic prenatal injury.
CONCLUSION: The proposed MR cerebellar algorithm was useful to guide genetic/malformative or biochemical investigations, allowing an etiological diagnosis in 55 children.
Copyright © 2010 Elsevier Masson SAS. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20378176     DOI: 10.1016/j.neurad.2009.12.009

Source DB:  PubMed          Journal:  J Neuroradiol        ISSN: 0150-9861            Impact factor:   3.447


  10 in total

1.  Neurology of inherited glycosylation disorders.

Authors:  Hudson H Freeze; Erik A Eklund; Bobby G Ng; Marc C Patterson
Journal:  Lancet Neurol       Date:  2012-05       Impact factor: 44.182

2.  Mild clinical and biochemical phenotype in two patients with PMM2-CDG (congenital disorder of glycosylation Ia).

Authors:  M Casado; M M O'Callaghan; R Montero; C Pérez-Cerda; B Pérez; P Briones; E Quintana; J Muchart; A Aracil; M Pineda; R Artuch
Journal:  Cerebellum       Date:  2012-06       Impact factor: 3.847

Review 3.  Childhood cerebellar ataxia.

Authors:  Brent L Fogel
Journal:  J Child Neurol       Date:  2012-07-04       Impact factor: 1.987

4.  Diagnostic approach to childhood-onset cerebellar atrophy: a 10-year retrospective study of 300 patients.

Authors:  Almundher Al-Maawali; Susan Blaser; Grace Yoon
Journal:  J Child Neurol       Date:  2012-07-04       Impact factor: 1.987

5.  Channelopathies Are a Frequent Cause of Genetic Ataxias Associated with Cerebellar Atrophy.

Authors:  Laurence Gauquelin; Taila Hartley; Mark Tarnopolsky; David A Dyment; Bernard Brais; Michael T Geraghty; Martine Tétreault; Sohnee Ahmed; Samantha Rojas; Karine Choquet; Jacek Majewski; François Bernier; Allan Micheil Innes; Guy Rouleau; Oksana Suchowersky; Kym M Boycott; Grace Yoon
Journal:  Mov Disord Clin Pract       Date:  2020-09-29

6.  Heterozygous Mutations in the ADCK3 Gene in Siblings with Cerebellar Atrophy and Extreme Phenotypic Variability.

Authors:  Lubov Blumkin; Esther Leshinsky-Silver; Ayelet Zerem; Keren Yosovich; Tally Lerman-Sagie; Dorit Lev
Journal:  JIMD Rep       Date:  2013-09-19

7.  Mutations in LAMA1 cause cerebellar dysplasia and cysts with and without retinal dystrophy.

Authors:  Kimberly A Aldinger; Stephen J Mosca; Martine Tétreault; Jennifer C Dempsey; Gisele E Ishak; Taila Hartley; Ian G Phelps; Ryan E Lamont; Diana R O'Day; Donald Basel; Karen W Gripp; Laura Baker; Mark J Stephan; Francois P Bernier; Kym M Boycott; Jacek Majewski; Jillian S Parboosingh; A Micheil Innes; Dan Doherty
Journal:  Am J Hum Genet       Date:  2014-08-07       Impact factor: 11.025

8.  Nuclear-mitochondrial proteins: too much to process?

Authors:  Rita Horvath; Patrick F Chinnery
Journal:  Brain       Date:  2015-06       Impact factor: 13.501

9.  The use of muscle biopsy in the diagnosis of undefined ataxia with cerebellar atrophy in children.

Authors:  Alessandra Terracciano; Florence Renaldo; Ginevra Zanni; Adele D'Amico; Anna Pastore; Sabina Barresi; Enza Maria Valente; Fiorella Piemonte; Giulia Tozzi; Rosalba Carrozzo; Massimiliano Valeriani; Renata Boldrini; Eugenio Mercuri; Filippo Maria Santorelli; Enrico Bertini
Journal:  Eur J Paediatr Neurol       Date:  2011-08-27       Impact factor: 3.140

10.  Utility of whole exome sequencing for the early diagnosis of pediatric-onset cerebellar atrophy associated with developmental delay in an inbred population.

Authors:  Hisham Megahed; Michaël Nicouleau; Giulia Barcia; Daniel Medina-Cano; Karine Siquier-Pernet; Christine Bole-Feysot; Mélanie Parisot; Cécile Masson; Patrick Nitschké; Marlène Rio; Nadia Bahi-Buisson; Isabelle Desguerre; Arnold Munnich; Nathalie Boddaert; Laurence Colleaux; Vincent Cantagrel
Journal:  Orphanet J Rare Dis       Date:  2016-05-04       Impact factor: 4.123

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.